GO:0070434 positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070434 describes any process that activates or increases the frequency, rate, or extent of NOD2 signaling, a cytosolic innate immune sensing pathway.
• NOD2 detects bacterial muramyl dipeptide (MDP) and triggers NF-kB and MAPK activation, pro-inflammatory cytokine production, and in some contexts pyroptosis.
• Positive regulation of NOD2 signaling is central to host defense but when dysregulated contributes to myocarditis, colitis, rheumatoid arthritis, atherosclerosis, and cancer immune resistance.
• Key positive regulators include NOD2 itself, RIPK2, XIAP, and downstream inflammasome components such as NLRP3 and caspase-1.
• Experimental dissection of this pathway relies on CRISPR knockout, point-mutation, knock-in, and overexpression models combined with cytokine profiling, imaging, and transcriptomics.
• The pathway is a therapeutic target: MDP-NOD2 inhibition ameliorates experimental colitis, and NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer.
Description
GO:0070434, positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway, is a biological process term that captures any molecular event that activates or increases the frequency, rate, or extent of NOD2 signaling. NOD2 is a cytosolic pattern-recognition receptor that senses bacterial muramyl dipeptide (MDP) and assembles a signaling platform to activate NF-kB and MAPK-dependent inflammatory programs. Because NOD2 signaling is a first-line innate immune response, its positive regulation is critical for pathogen clearance but also a driver of inflammatory pathology when uncontrolled. Researchers study GO:0070434 to understand how innate immune activation is amplified, how it intersects with inflammasome biology, and how it can be modulated therapeutically in infectious, autoimmune, cardiovascular, and oncologic disease. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, genes, disease links, and experimental methods relevant to this term.
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway At A Glance
| GO ID | GO:0070434 |
|---|---|
| GO term | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| Ontology | biological_process |
| Synonym | positive regulation of NOD2 signaling pathway; positive regulation of nucleotide-binding oligomerization domain containing 2 signalling pathway |
| Major function | Amplification of cytosolic innate immune sensing through NOD2, leading to NF-kB/MAPK activation, cytokine production, and inflammatory cell death |
| Key ligands | Muramyl dipeptide (MDP) from bacterial peptidoglycan |
| Key downstream effectors | RIPK2, XIAP, NLRP3 inflammasome, caspase-1, NF-kB, MAPKs |
| Disease relevance | Myocarditis, colitis, rheumatoid arthritis, atherosclerosis, cancer immune resistance |
What Is GO:0070434?
According to QuickGO, GO:0070434 is defined as any process that activates or increases the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway. In practice, this includes molecular events that enhance NOD2 ligand sensing, promote NOD2 oligomerization and RIPK2 recruitment, amplify downstream NF-kB and MAPK signaling, or sustain inflammatory cytokine and pyroptotic outputs.
Why Is positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway Important in Cell Biology?
Positive regulation of NOD2 signaling is important because it determines the strength and duration of innate immune activation against bacterial pathogens while also shaping sterile inflammation in autoimmune and cardiovascular disease. Dysregulated amplification of this pathway can drive tissue damage, as shown in coxsackievirus B3-induced myocarditis where NOD2 is a major pathogenic mediator, and in rheumatoid arthritis where ERAP2 regulates CD4+ T cell pyroptosis through inflammasome-related mechanisms. Conversely, NOD1/2 signaling in macrophages can promote adaptive immune resistance in cancer, highlighting its relevance to immuno-oncology. Understanding GO:0070434 therefore informs host-directed therapies, anti-inflammatory drug development, and cancer immunotherapy strategies.
• Defines the amplification arm of cytosolic innate immunity against bacterial MDP.
• Controls NF-kB and MAPK-dependent cytokine production in macrophages and epithelial cells.
• Links to inflammasome activation and pyroptosis through NLRP3 and caspase-1.
• Is a pathogenic mediator in viral myocarditis, as shown for coxsackievirus B3.
• Contributes to chronic inflammatory diseases such as rheumatoid arthritis and colitis.
• Plays a role in atherosclerosis through NOD-like receptor inflammasome regulation.
• Drives adaptive immune resistance in cancer via NOD1/2 signaling in macrophages.
• Is modulated by redox regulation of NLRs, connecting oxidative stress to NOD2 signaling.
• Represents a druggable node: MDP-NOD2 inhibition ameliorates experimental colitis.
• Provides a mechanistic basis for CRISPR-based functional genomics of innate immunity.
What Happens During positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway?
Ligand sensing and NOD2 activation
In simple terms: NOD2 detects bacterial cell wall fragments inside the cell, which switches it on.
NOD2 is a cytosolic sensor of muramyl dipeptide (MDP), a component of bacterial peptidoglycan. Positive regulation begins with enhanced ligand availability or sensing, leading to NOD2 conformational activation and oligomerization. In experimental colitis, gram-positive bacteria-dependent MDP-NOD2 signaling is a key driver, and its inhibition by paeoniflorin ameliorates disease. Redox regulation of NLR family members can also influence NOD2 activation status, linking oxidative stress to pathway amplification.
RIPK2 recruitment and signalosome assembly
In simple terms: Activated NOD2 builds a molecular platform that recruits the kinase RIPK2 to relay the signal.
Upon activation, NOD2 recruits RIPK2 through CARD-CARD interactions, forming a signalosome that is stabilized by XIAP and other E3 ligases. This assembly is a critical positive regulatory step because it determines the efficiency of downstream NF-kB and MAPK activation. NOD1/2 signaling in macrophages has been shown to drive adaptive immune resistance in cancer, indicating that signalosome output can shape tumor-immune interactions.
NF-kB and MAPK activation
In simple terms: The signalosome turns on transcription factors that switch on inflammatory genes.
RIPK2-dependent signaling activates the NF-kB and MAPK cascades, leading to transcription of pro-inflammatory cytokines and chemokines. This transcriptional output is the functional readout of positive regulation of NOD2 signaling. In cardiovascular contexts, NOD-like receptor protein 3 inflammasome regulation by endothelial cells contributes to atherosclerosis, illustrating how NOD2-adjacent signaling integrates into vascular inflammation.
Inflammasome engagement and pyroptosis
In simple terms: Strong NOD2 signaling can trigger a cell death program called pyroptosis.
Positive regulation of NOD2 signaling can intersect with NLRP3 inflammasome activation, caspase-1 cleavage, and pyroptosis. In rheumatoid arthritis, ERAP2 regulates CD4+ T cell pyroptosis, linking NOD2-related innate sensing to adaptive immune cell death. The ROS/GRK2/HIF-1alpha/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes, further connecting redox and hypoxic signals to inflammasome-driven pathology.
Resolution and negative feedback
In simple terms: The pathway must be switched off to avoid chronic inflammation.
Although GO:0070434 focuses on positive regulation, sustained activation is counterbalanced by negative feedback mechanisms including degradation of signaling components and anti-inflammatory cytokines. Redox regulation of NLRs can either amplify or restrain inflammasome activity depending on context. Intermittent fasting has been shown to modulate SIRT-1/NRF2/P38 MAPK/NLRP3 signaling, indicating that metabolic interventions can influence NOD2-related inflammatory tone.
Key Genes Involved in GO:0070434 positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
The following genes and proteins are central to positive regulation of NOD2 signaling, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOD2 | Cytosolic sensor of MDP; initiates signaling | Core receptor for GO:0070434; target in colitis and myocarditis |
| RIPK2 | Kinase recruited to NOD2; activates NF-kB/MAPK | Central signalosome component; drug target |
| XIAP | E3 ligase stabilizing NOD2-RIPK2 complex | Positive regulator of NOD2 signaling |
| NLRP3 | Inflammasome sensor; mediates pyroptosis | Links NOD2 signaling to inflammatory cell death |
| CASP1 | Caspase-1; executes pyroptosis | Effector of inflammasome activation downstream of NOD2 |
| ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Regulates CD4+ T cell pyroptosis in rheumatoid arthritis |
| GRK2 | G protein-coupled receptor kinase 2 | Mediates ROS/HIF-1alpha/NLRP3 pathway in synoviocytes |
| HIF1A | Hypoxia-inducible factor 1-alpha | Connects hypoxia to NLRP3 inflammasome |
| SIRT1 | NAD-dependent deacetylase | Modulates NLRP3 via SIRT-1/NRF2/P38 MAPK |
| NFE2L2 | NRF2; antioxidant transcription factor | Regulates redox balance and inflammasome activity |
| MAPK14 | P38 MAPK; stress-activated kinase | Downstream of NOD2; regulates cytokine production |
| NFKB1 | NF-kB subunit; transcription factor | Mediates inflammatory gene expression downstream of NOD2 |
| NOD1 | Related NLR sensor | Cooperates with NOD2 in macrophage immune resistance |
| IL1B | Interleukin-1 beta | Cytokine output of inflammasome activation |
| IL18 | Interleukin-18 | Cytokine output of inflammasome activation |
| GSDMD | Gasdermin D; pyroptosis executor | Pore-forming protein in pyroptosis |
| TNF | Tumor necrosis factor | Pro-inflammatory cytokine induced by NOD2 signaling |
How Is positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway Regulated?
Positive regulation of NOD2 signaling is controlled at multiple levels. Redox regulation of NLR family members modulates inflammasome activity and can either amplify or dampen NOD2-dependent responses. Metabolic and stress pathways, including SIRT-1/NRF2/P38 MAPK, influence NLRP3 inflammasome activity and thus downstream inflammatory tone. In disease contexts, ERAP2 regulates CD4+ T cell pyroptosis, providing an additional layer of post-transcriptional control. Pharmacological inhibition of MDP-NOD2 signaling by paeoniflorin ameliorates experimental colitis, demonstrating that this pathway is druggable.
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOD2 | Coxsackievirus B3-induced myocarditis | Nod2 knockout mouse; cardiac immune profiling |
| NOD2 | Experimental colitis | MDP-induced colitis model; paeoniflorin treatment |
| ERAP2 | Rheumatoid arthritis | CD4+ T cell pyroptosis assay; ERAP2 knockdown |
| NLRP3 | Atherosclerosis | Endothelial cell inflammasome model |
| NOD1/NOD2 | Cancer adaptive immune resistance | Macrophage-tumor co-culture; knockout models |
Infectious and cardiovascular disease
NOD2 is a major pathogenic mediator of coxsackievirus B3-induced myocarditis, where positive regulation of NOD2 signaling drives cardiac inflammation and injury. Endothelial NLRP3 inflammasome regulation contributes to atherosclerosis, linking NOD-like receptor signaling to vascular disease. These findings position GO:0070434 as a therapeutic node in infection-triggered and sterile cardiovascular inflammation.
Autoimmune and inflammatory disease
In rheumatoid arthritis, ERAP2 regulates CD4+ T cell pyroptosis, implicating NOD2-related innate sensing in autoimmune joint destruction. The ROS/GRK2/HIF-1alpha/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes, further supporting a role for inflammasome amplification in arthritis. In experimental colitis, gram-positive bacteria-dependent MDP-NOD2 signaling is a driver of inflammation, and its inhibition is protective.
Cancer and immuno-oncology
NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer, indicating that positive regulation of NOD2 signaling can shape tumor immune evasion. This creates opportunities for combining NOD2 pathway modulation with immune checkpoint blockade. The pathway is therefore relevant to both tumor immunology and host-directed anticancer therapy.
From positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NOD2 drive myocarditis pathogenesis? | Nod2 knockout mouse with coxsackievirus B3 infection |
| Can MDP-NOD2 signaling be inhibited to treat colitis? | Experimental colitis with paeoniflorin treatment |
| How does ERAP2 regulate T cell pyroptosis? | ERAP2 knockout or knockdown in CD4+ T cells |
| What is the role of NOD1/2 in cancer immune resistance? | Macrophage-specific NOD1/2 knockout in tumor models |
| How does redox regulation affect NLR inflammasome? | Antioxidant or ROS modulator treatment in cell models |
| Does intermittent fasting modulate NLRP3 via SIRT-1/NRF2? | High-fat diet rat model with intermittent fasting |
How to Study the positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Cytokine secretion (IL-1beta, TNF) | NOD2 activation readout |
| Western blot | Cleaved caspase-1, gasdermin D | Pyroptosis confirmation |
| RNA-seq | Transcriptional changes | NF-kB/MAPK target gene profiling |
| Immunofluorescence | NF-kB nuclear translocation, ASC specks | Spatial pathway activation |
| CRISPR knockout | Gene function loss | Causal testing of NOD2 pathway genes |
| Flow cytometry | Immune cell activation and death | T cell pyroptosis and macrophage phenotyping |
| Luminex | Multiplex cytokine profiling | Inflammatory signature analysis |
| Seahorse assay | Metabolic flux | Immunometabolism of activated macrophages |
Cytokine and inflammasome profiling
Measuring IL-1beta, IL-18, and TNF secretion by ELISA or Luminex after MDP stimulation is a standard readout of positive regulation of NOD2 signaling. Caspase-1 activity assays and Western blot for cleaved gasdermin D confirm pyroptosis engagement.
Transcriptomics and pathway analysis
RNA-seq after NOD2 activation reveals NF-kB and MAPK target gene signatures. Pathway enrichment can identify co-regulated inflammatory modules and candidate positive regulators. Single-cell RNA-seq is useful for dissecting macrophage and T cell responses in tumors.
Imaging and cell death assays
Live-cell imaging of ASC speck formation and propidium iodide uptake quantifies inflammasome assembly and pyroptosis. Immunofluorescence for NF-kB nuclear translocation provides a spatial readout of NOD2 pathway activation.
Genetic perturbation with CRISPR
CRISPR knockout of NOD2, RIPK2, or ERAP2 followed by MDP stimulation tests causality. Point mutations in NOD2 can model disease-associated variants, while knock-in reporters enable real-time pathway monitoring.
How CRISPR Can Be Used to Study GO:0070434 positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
Knockout
CRISPR knockout of NOD2, RIPK2, or ERAP2 is used to test whether these genes are required for positive regulation of NOD2 signaling. Nod2 knockout mice confirm the pathogenic role of NOD2 in coxsackievirus B3-induced myocarditis. In vitro knockout of ERAP2 in CD4+ T cells reveals its role in pyroptosis.
Point Mutation
Point mutations can model disease-associated NOD2 variants or disrupt catalytic residues in RIPK2 to dissect signaling domains. These models help distinguish gain-of-function from loss-of-function effects in inflammatory disease.
Knock-in
Knock-in of fluorescent or epitope tags into NOD2 or RIPK2 enables real-time tracking of signalosome assembly and localization. Reporter knock-ins can quantify pathway activation in live cells.
Overexpression
Overexpression of NOD2, RIPK2, or constitutively active mutants amplifies pathway output and is useful for identifying downstream effectors. Overexpression models in macrophages can mimic the adaptive immune resistance phenotype seen in cancer.
How EDITGENE Supports positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway Research
Researchers studying positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in NOD2 pathway amplification or is merely a bystander. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of NOD2, RIPK2, ERAP2, NLRP3, and other pathway components, accelerating mechanistic and translational studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway research.
Frequently Asked Questions About positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
What is GO:0070434?
GO:0070434 is the Gene Ontology term for positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway, describing any process that activates or increases NOD2 signaling.
What genes are involved in positive regulation of NOD2 signaling?
Key genes include NOD2, RIPK2, XIAP, NLRP3, CASP1, ERAP2, and downstream NF-kB/MAPK components.
What does NOD2 signaling do?
NOD2 senses bacterial muramyl dipeptide and activates NF-kB and MAPK pathways, leading to inflammatory cytokine production and sometimes pyroptosis.
How is NOD2 signaling regulated?
It is regulated by ligand availability, redox status, E3 ligases such as XIAP, and metabolic pathways including SIRT-1/NRF2/P38 MAPK.
What diseases are linked to NOD2 signaling?
NOD2 signaling is linked to coxsackievirus B3-induced myocarditis, colitis, rheumatoid arthritis, atherosclerosis, and cancer immune resistance.
How can I study positive regulation of NOD2 signaling in the lab?
Common methods include MDP stimulation with cytokine ELISA, CRISPR knockout of pathway genes, RNA-seq, and imaging of NF-kB translocation or ASC specks.
What is the role of RIPK2 in NOD2 signaling?
RIPK2 is a kinase recruited to activated NOD2 that relays signals to NF-kB and MAPK, making it a central positive regulator.
Can NOD2 signaling be targeted therapeutically?
Yes, inhibition of MDP-NOD2 signaling by paeoniflorin ameliorates experimental colitis, and NOD1/2 signaling is a target in cancer immunotherapy.
What is the connection between NOD2 and pyroptosis?
Strong NOD2 signaling can activate the NLRP3 inflammasome and caspase-1, leading to gasdermin D-mediated pyroptosis.
Which CRISPR models are best for NOD2 pathway research?
Knockout models test requirement, point mutations dissect domains, knock-in reporters track dynamics, and overexpression amplifies signaling for effector discovery.
Conclusion
GO:0070434, positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway, is a central node in cytosolic innate immunity that amplifies inflammatory responses to bacterial MDP and shapes outcomes in infectious, autoimmune, cardiovascular, and oncologic disease. Understanding its positive regulators, from NOD2 and RIPK2 to inflammasome components, provides a foundation for therapeutic intervention and biomarker discovery. CRISPR-based cell models and functional genomics are essential tools for dissecting this pathway and translating findings into clinical applications.
References
- 1. Guo S et al.. 2024. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis.. Cardiovasc Res 120(8):883-898 PMID: 38626254
- 2. Ferrara F et al.. 2023. Redox Regulation of Nucleotide-Binding and Oligomerization Domain-Like Receptors Inflammasome.. Antioxid Redox Signal 39(10-12):744-770 PMID: 37440315
- 3. Tschöpe C et al.. 2017. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.. Circ Heart Fail 10(9) PMID: 28912259
- 4. Wei X et al.. 2026. NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer.. Signal Transduct Target Ther 11(1) PMID: 42476973
- 5. Zhang J et al.. 2024. Endoplasmic reticulum aminopeptidase 2 regulates CD4(+) T cells pyroptosis in rheumatoid arthritis.. Arthritis Res Ther 26(1):36 PMID: 38273310
- 6. Hong Z et al.. 2022. The ROS/GRK2/HIF-1α/NLRP3 Pathway Mediates Pyroptosis of Fibroblast-Like Synoviocytes and the Regulation of Monomer Derivatives of Paeoniflorin.. Oxid Med Cell Longev 2022:4566851 PMID: 35132350
- 7. Luo X et al.. 2021. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway.. Int Immunopharmacol 90:107224 PMID: 33302036
- 8. Hemead DA et al.. 2025. Intermittent fasting restores fertility dysfunction caused by a high-fat diet in male rats: role of SIRT-1/NRF2/P38 MAPK/NLRP3.. Reprod Fertil Dev 37 PMID: 40977219
